Astera Labs (ALAB) awards RSUs to chief accounting officer

Rhea-AI Filing Summary

Astera Labs, Inc. reported that Chief Accounting Officer and VP, Finance Cota Germaine received two equity awards on February 2, 2026. The awards total 24,933 restricted stock units (RSUs), each RSU representing one share of common stock.

One grant covers 21,817 RSUs that vest 25% on February 15, 2027, with the remaining 75% vesting in 12 equal quarterly installments afterward, contingent on continued service. A second grant of 3,116 RSUs vests 100% on February 15, 2027, also subject to ongoing service. Following these grants, Germaine directly holds 24,989 shares of common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Cota Germaine

Role Chief Accting. Off. & VP, Fin.

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	21,817	$0.00	--
Grant/Award	Common Stock	3,116	$0.00	--

Holdings After Transaction: Common Stock — 21,873 shares (Direct)

Footnotes (1)

1. These shares represent an award of restricted stock units ("RSUs") granted on February 2, 2026 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan (the "Plan"). Such award provides that the RSUs shall vest as to 25% on February 15, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. These shares represent an award of RSUs granted on February 2, 2026 under the Plan. Such award provides that the RSUs shall vest as to 100% on February 15, 2027, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cota Germaine

(Last) (First) (Middle)

C/O ASTERA LABS, INC.

2345 NORTH FIRST STREET

(Street)

SAN JOSE CA 95131

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Astera Labs, Inc. [ ALAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accting. Off. & VP, Fin.

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/02/2026		A		21,817(1)	A	$0	21,873	D
Common Stock	02/02/2026		A		3,116(2)	A	$0	24,989	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent an award of restricted stock units ("RSUs") granted on February 2, 2026 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan (the "Plan"). Such award provides that the RSUs shall vest as to 25% on February 15, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

2. These shares represent an award of RSUs granted on February 2, 2026 under the Plan. Such award provides that the RSUs shall vest as to 100% on February 15, 2027, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Remarks:

	/s/ Philip Mazzara, Attorney-in-Fact	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Astera Labs (ALAB) report for Cota Germaine?

Astera Labs reported equity awards to Cota Germaine. On February 2, 2026, the Chief Accounting Officer and VP, Finance received two grants totaling 24,933 restricted stock units (RSUs), each representing one share of common stock, as part of the company’s 2024 Stock Option and Incentive Plan.

How many Astera Labs (ALAB) RSUs were granted to Cota Germaine on February 2, 2026?

Cota Germaine received a total of 24,933 RSUs. One award covers 21,817 RSUs and another covers 3,116 RSUs. Each RSU corresponds to one share of Astera Labs common stock, subject to the specified vesting schedules and continued service conditions.

What are the vesting terms of Cota Germaine’s 21,817 Astera Labs (ALAB) RSU grant?

The 21,817 RSUs vest over several years. 25% vest on February 15, 2027, and the remaining 75% vest in 12 equal quarterly installments thereafter, provided Cota Germaine maintains a continuous service relationship with Astera Labs through each vesting date.

When do the additional 3,116 Astera Labs (ALAB) RSUs granted to Cota Germaine vest?

The 3,116 RSUs vest in a single tranche. This award vests 100% on February 15, 2027, assuming Cota Germaine continues in a service relationship with Astera Labs through that date, as required under the company’s 2024 Stock Option and Incentive Plan.

How many Astera Labs (ALAB) shares does Cota Germaine own after the reported Form 4 transactions?

Cota Germaine beneficially owns 24,989 common shares after the grants. The Form 4 shows this total direct ownership following the February 2, 2026 RSU awards reported as acquired at a price of $0 per share.

Under which plan were Cota Germaine’s Astera Labs (ALAB) RSU awards granted?

The RSUs were granted under Astera Labs’ 2024 Stock Option and Incentive Plan. Both the 21,817-unit and 3,116-unit RSU awards reference this plan, with vesting contingent on Cota Germaine’s continued service with the company through the applicable vesting dates.